Evaluation of Immersive Audiovisual Distraction Impact on Peroperative Opioid Consumption.
- Conditions
- AnalgesiaSurgical Procedure, UnspecifiedOutpatient
- Interventions
- Device: Audiovisual distraction deviceDevice: Analgesia nociception index
- Registration Number
- NCT04238572
- Lead Sponsor
- University Hospital, Caen
- Brief Summary
This study evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption for outpatient procedures with Remifentanil added to local anesthesia.
Half of patients will receive an audiovisual distraction device while the other half not.
- Detailed Description
Early recovery for patients undergoing surgery is the key factor for an outpatient procedure.
The technique of adding remifentanil to a local anesthesia is used in 22% of the procedures realized in The CHU de Caen Outpatient unit. Decreasing opioid dose, whose side effects are numerous and widely described, as well as reducing anxiety are daily challenges to ensure comfort and successful care.
We propose a prospective, randomized, monocentric, open label study to evaluate the impact of the use of an audiovisual distraction device on the intraoperative consumption of opioids, on the patient's pain and peroperative anxiety.
ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement. We will analyze if audiovisual distraction can integrate existing techniques such as hypnosis.
Finally, we will also assess the medico-economic impact of this technique in order to establish a benefit / cost ratio.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Adult patient
- Signed consent
- Outpatient surgery eligibility
- Patient covered by social security
- Unsigned consent
- Study participation refusal
- Deafness, blindness
- Claustrophobia
- ANI contraindication (atrial fibrillation, pace maker, severe autonomic system dysfunction)
- Contraindication or impossibility to use the audiovisual distraction device
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Audiovisual distraction device Audiovisual distraction device Audiovisual distraction device, analgesia nociception index monitoring, remifentanil added to local anesthesia technique Active comparator group Analgesia nociception index Analgesia nociception index monitoring, remifentanil added to local anesthesia technique Audiovisual distraction device Analgesia nociception index Audiovisual distraction device, analgesia nociception index monitoring, remifentanil added to local anesthesia technique
- Primary Outcome Measures
Name Time Method Intraoperative Remifentanil dose 1 hour μg/kg/min
- Secondary Outcome Measures
Name Time Method Post operative anxiety measured by a visual analogue scale (VAS) 1 hour Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement "not anxious at all" and at the right hand (100mm) the statement "most anxious I can imagine"
Preoperative pain measured with a numeric pain rating scale (NRS) 1 hour Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)
Preoperative anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS) 1 hour APAIS measures the need-for-information with 6 items. Each one is rated from 1 = Not at all to 5 = Extremely. There is positive and significant correlation between the ned-for-information and anxiety.
Preoperative anxiety measured by a visual analogue scale (VAS) 1 hour Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement "not anxious at all" and at the right hand (100mm) the statement "most anxious I can imagine"
Per operative Analgesia nociception index (ANI) value 1 hour From 0 = Predominant sympathetic tone, pain and anxiety to 100 = Predominant parasympathetic tone, good analgesia.
Negative linear Relationship between analgesia nociception index and pain scoresPostoperative pain measured with a numeric pain rating scale (NRS) 1 hour Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)
Trial Locations
- Locations (1)
Caen University Hospital
🇫🇷Caen, Calvados, France